Odevixibat
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Progressive familial intrahepatic cholestasis disease burden and clinical approaches: a systematic review.
Journal: Journal of comparative effectiveness research
Published: August 19, 2026
Biliary atresia-related liver fibrosis.
Journal: Frontiers in cell and developmental biology
Published: June 10, 2026
Parvovirus B19 infection as a trigger of acute cholestasis in heterozygous genetic BSEP deficiency: a case report and review of the literature of acute parvovirus B19-related hepatitis.
Journal: Internal and emergency medicine
Published: February 12, 2026
Review Article: Ileal Bile Acid Transport (IBAT) Inhibitors as an Emerging Treatment for Cholestatic Liver Disease.
Journal: Alimentary pharmacology & therapeutics
Published: December 02, 2025
Remarkable Response to Odevixibat in an Adult With Progressive Familial Intrahepatic Cholestasis Type 1 and Intractable Pruritus.
Journal: ACG case reports journal
Published: November 20, 2025
Odevixibat ameliorates high-fat diet-induced MASLD in mice by targeting the gut microbiota-metabolite axis and enhancing gut-liver crosstalk.
Journal: Journal of physiology and biochemistry
Published: November 18, 2025
Ileal Bile Acid Transporter Inhibitors in Cholestasis: Potential for More Than Just Paediatrics?
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 17, 2025
Insights into Transport Function of the Murine Organic Anion-Transporting Polypeptide OATP1B2 by Comparison with Its Rat and Human Orthologues.
Journal: Toxics
Published: November 06, 2025
Letter to The Editor, Regarding "Indirect Comparison of Maralixibat and Odevixibat for the Treatment of Progressive Familial Intrahepatic Cholestasis" Recently Published by Lacey and Colleagues.
Journal: Clinical therapeutics
Published: October 31, 2025
Odevixibat treatment for recurrent cholestasis in a patient with biallelic UNC45A variants causing osteo-oto-hepato-enteric syndrome.
Journal: JHEP reports : innovation in hepatology
Published: October 17, 2025
An update on novel investigational agents for the treatment of primary biliary cholangitis.
Journal: Expert opinion on investigational drugs
Published: October 13, 2025
Last Updated: 09/26/2026